IL1B and Sepsis: In a mouse sepsis model induced by APEC and MRSA, A7 treatment significantly improved survival rates (60-80%), reduced bacterial loads in vital organs, and attenuated the systemic cytokine storm (<i>TNF-α</i> and <i>IL-1β</i>), thereby alleviating immune-mediated tissue damage.